Joint Clinical Committees definition

Joint Clinical Committees has the meaning given in section 8.1.
Sample 1Sample 2Sample 3

Examples of Joint Clinical Committees in a sentence

  • In collaboration with the Doctors of BC and the Joint Clinical Committees, conduct a review of the existing work underway by the various Joint Clinical Committees with a view to aligning system-wide improvement and quality activities across all of the committees.

  • The term “Joint Collaborative Committees” refers to the three Joint Clinical Committees and the Joint Standing Committee on Rural Issues.

  • The Doctors of BC shall indemnify and hold harmless the Government from and against any and all claims arising from or in connection with the administration of the Joint Clinical Committees.

  • As defined in the Physician Master Agreement the Joint Clinical Committees are the General Practice Services Committee, the SpecialistServices Committee, and the Shared Care Committee.

  • A number of training options were discussed by the WG, including: BCPSQC’s New Clinician Quality Academy (to be delivered locally in IH) PMI courses, (in-house) IHI Online TrainingSome of the above training options are funded by the Joint Clinical Committees and these existing options would be leveraged prior to using any of the $65,000 training budget.

  • At first glance the broader sessional fund may appear to be similar to the “Physician Engagement in Health Authority Redesign Fund” that is provided by the Joint Clinical Committees.

Related to Joint Clinical Committees

  • Technical Committee means the body established in accordance with article VII;

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 3.4 (Joint Commercialization Committee).

  • Regulatory Oversight Committee means the committee of the Board constituted in accordance with Rule 204.

  • Medical Advisory Committee means the Medical Advisory Committee established by the Board as required by the Public Hospitals Act;

  • JDC has the meaning set forth in Section 3.2.

  • Joint Committee means the Joint Committee established by Article 164(1) of the withdrawal agreement;

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.

  • Technical Advisory Committee means a committee established under section 12;

  • Ethics Committee means an independent body established in a Member State in accordance with the law of that Member State and empowered to give opinions for the purposes of this Regulation, taking into account the views of laypersons, in particular patients or patients' organisations;

  • JCC has the meaning set forth in Section 3.1.

  • JSC has the meaning set forth in Section 3.1.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Joint Research Committee or “JRC” has the meaning set forth in Section 3.1.1.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Development Committee has the meaning set forth in Article 3 of the Amended and Restated Research and Development Agreement.

  • OPSI Advisory Committee means the committee established under Tariff, Attachment M, section III.G.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Steering Committee shall have the meaning set forth in Section 3.1.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Screening Committee means the State level Screening Committee constituted in terms of sub-rule (2) of rule 123 of these rules.